Table 2.
Adjusted mean of trans fatty acids and plasma antioxidant levels in patients with and without peripheral artery disease (PAD)
| Participants | P-value | ||
|---|---|---|---|
| With PAD | Without PAD | ||
| Trans 9-hexadecenoic acid(uM) | 6.5 ± 0.12 | 6.1 ± 0.19 | 0.842 |
| Trans 11-octadecenoic acid (uM) | 38.1 ± 0.36 | 34.1 ± 0.92 | 0.265 |
| Trans 9-octadecenoic acid (uM) | 35.2 ± 0.35 | 30.6 ± 0.62 | < 0.001 |
| Trans 9, trans 12-octadienoic acid (uM) | 2.8 ± 0.12 | 2.4 ± 0.31 | < 0.001 |
| Vitamin D (nmol/L) | 54.3 ± 0.28 | 57.1 ± 0.72 | < 0.001 |
| Retinol(μg/dL) | 60.2 ± 0.62 | 68.4 ± 0.64 | < 0.001 |
| Retinyl stearate(μg/dL) | 0.43 ± 0.01 | 0.87 ± 0.01 | < 0.001 |
| Retinyl palmitate(μg/dL) | 2.1 ± 0.28 | 3.0 ± 0.10 | < 0.001 |
Analysis of covariance applied to calculate age, race, diabetes, hypertension, cholesterol, smoking and energy intake adjusted mean of dietary score. Value expressed as mean ± SEM